These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26739586)

  • 1. Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.
    Persu A; Kjeldsen S; Staessen JA; Azizi M
    Curr Hypertens Rep; 2016 Jan; 18(1):6. PubMed ID: 26739586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
    Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension.
    Schlaich MP
    Am J Hypertens; 2017 Sep; 30(9):847-856. PubMed ID: 28338871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
    Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
    Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
    Epstein M; de Marchena E
    J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
    Esler M
    J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Denervation: Is It Ready for Prime Time?
    Lauder L; Wolf MA; Scholz SS; Hohl M; Mahfoud F; Böhm M
    Curr Cardiol Rep; 2019 Jul; 21(8):80. PubMed ID: 31278490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal denervation: a new therapeutic approach for resistant hypertension.
    Cao L; Fu Q; Wang B; Li Z
    Chin Med J (Engl); 2014; 127(18):3302-8. PubMed ID: 25266531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.
    Kandzari DE; Kario K; Mahfoud F; Cohen SA; Pilcher G; Pocock S; Townsend R; Weber MA; Böhm M
    Am Heart J; 2016 Jan; 171(1):82-91. PubMed ID: 26699604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Position paper on the results of Symplicity HTN-3 trial. Grupo de estudio de la hipertensión arterial resistente].
    Azpiri-López JR; Assad-Morell JL; Ponce de León-Martínez E; Monreal-Puente R; Dávila-Bortoni A; Vázquez-Díaz LA; Treviño-Frutos RJ; Barrera-Oranday F; Del Angel-Soto JG; Martínez JG; Arellano-Torres M
    Arch Cardiol Mex; 2015; 85(2):154-7. PubMed ID: 25700579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation after Symplicity HTN-3: an update.
    Persu A; Jin Y; Fadl Elmula FE; Jacobs L; Renkin J; Kjeldsen S
    Curr Hypertens Rep; 2014 Aug; 16(8):460. PubMed ID: 24913923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal denervation--hypes and hopes.
    Lewek J; Kaczmarek K; Pokushalov E; Romanov A; Cygankiewicz I; Ptaszynski P
    Cardiovasc Ther; 2015 Jun; 33(3):141-4. PubMed ID: 25786785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinnervation following catheter-based radio-frequency renal denervation.
    Booth LC; Nishi EE; Yao ST; Ramchandra R; Lambert GW; Schlaich MP; May CN
    Exp Physiol; 2015 Apr; 100(5):485-90. PubMed ID: 25573386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
    ; Esler MD; Krum H; Sobotka PA; Schlaich MP; Schmieder RE; Böhm M
    Lancet; 2010 Dec; 376(9756):1903-9. PubMed ID: 21093036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomic Patterns of Renal Arterial Sympathetic Innervation: New Aspects for Renal Denervation.
    Imnadze G; Balzer S; Meyer B; Neumann J; Krech RH; Thale J; Franz N; Warnecke H; Awad K; Hayek SS; Devireddy C
    J Interv Cardiol; 2016 Dec; 29(6):594-600. PubMed ID: 27687514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design.
    Böhm M; Townsend RR; Kario K; Kandzari D; Mahfoud F; Weber MA; Schmieder RE; Tsioufis K; Hickey GL; Fahy M; DeBruin V; Brar S; Pocock S
    Clin Res Cardiol; 2020 Mar; 109(3):289-302. PubMed ID: 32034481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal denervation for uncontrolled hypertension: critical review of the evidence.
    Chen C; Upadhyay A
    Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):114-122. PubMed ID: 27922849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium.
    Kario K; Kim BK; Aoki J; Wong AY; Lee YH; Wongpraparut N; Nguyen QN; Ahmad WAW; Lim ST; Ong TK; Wang TD
    Hypertension; 2020 Mar; 75(3):590-602. PubMed ID: 32008432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.